Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Simak Ali

35PUBLICATIONS
131CO-AUTHORS
Liquid biopsiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

Sort by Publication Date:
|Apr 08, 2026
Band-stop microfluidics for high-purity, label-free enrichment of viable cancer cells from whole blood.

Lewis Krzeczkowski, Georgios Nteliopoulos, Simak Ali

|Sep 08, 2025
Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cells.

Chun-Fui Lai, Victoria I Cushing, Ellen Olden

|Mar 06, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

R C Coombes, Sacha Howell, Simon R Lord

|Nov 15, 2024
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.

Nicola J Smith, Ian Reddin, Paige Policelli

|Oct 02, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.

Carolina Gemma, Chun-Fui Lai, Anup K Singh

|Jun 05, 2024
Analysis of Breast Cancer Brain Metastases Reveals an Enrichment of Cyclin-Dependent Kinase 12 Structural Rearrangements in Human Epidermal Growth Factor Receptor 2-Positive Disease.

Talvinder Bhogal, Athina Giannoudis, Ethan Sokol

Pageof 6

Frequent Collaborators

8 joint publications

R Charles Coombes

5 joint publications

Jacqueline Shaw

4 joint publications

Carlo Palmieri

4 joint publications

Lakjaya Buluwela

3 joint publications

Simon R Lord

3 joint publications

Luca Magnani

3 joint publications

Steffi Oesterreich

3 joint publications

Tim R Fenton

3 joint publications

Charlotte L Bevan

3 joint publications

Carolina Gemma

Frequent Collaborators

8 joint publications

R Charles Coombes

5 joint publications

Jacqueline Shaw

4 joint publications

Carlo Palmieri

4 joint publications

Lakjaya Buluwela

Top Related Videos

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on : Nov 14, 2025

963
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

15.2K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.7K
See more related videos

Top Related Videos

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on : Nov 14, 2025

963
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

15.2K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.7K
See more related videos